CRMA-1001 clinical trials

A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B

This study is testing a new medicine, CRMA-1001, for adults with long-term Hepatitis B. It aims to see if it's safe and how well it's tolerated, as well as checking how it works in the body. Participants will receive the medicine through a drip.